FENNEC PHARMACEUTICALS INC. (FENC)
↓ Download CSV- Sector Manufacturing
- Incorporated A1
- Fiscal year ends Dec 31
In fiscal 2025, FENNEC PHARMACEUTICALS INC. reported revenue of $44.64M, down 6.1% from the prior year. The company ran a net loss, with a net margin of -21.8%. It held $70.55M in total assets against $35.08M in total liabilities.
Key ratios (FY2025)
-14.1%
Operating margin
-21.8%
Net margin
-27.5%
Return on equity
-6.1%
Revenue growth (YoY)
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $44.64M | $47.54M | $21.25M | $1.53M | — | $170.0K | $0 | $0 | $0 | $0 |
| Cost of Revenue | — | — | $1.26M | $86.0K | — | — | — | — | — | — |
| Gross Profit | — | — | $19.99M | $1.45M | — | — | — | — | — | — |
| Operating Income | -$6.28M | $2.57M | -$12.77M | -$22.59M | -$17.22M | -$17.89M | -$13.01M | -$10.41M | -$6.95M | -$2.87M |
| Net Income | -$9.74M | -$436.0K | -$16.05M | -$23.71M | -$17.35M | -$18.11M | -$12.78M | -$9.89M | -$7.05M | -$2.79M |
| EPS (Diluted) | $-0.34 | $-0.02 | $-0.60 | $-0.90 | $-0.67 | $-0.76 | — | — | — | — |
| Total Assets | $70.55M | $44.95M | $26.86M | $26.94M | $22.41M | $31.42M | $14.15M | $22.95M | $28.40M | $3.97M |
| Total Liabilities | $35.08M | $50.82M | $38.49M | $29.51M | $6.64M | $2.35M | $2.27M | $1.64M | $1.64M | $402.0K |
| Shareholders' Equity | $35.47M | -$5.87M | -$11.62M | -$2.57M | $15.77M | $29.07M | $11.88M | $21.31M | $26.76M | $3.57M |
| Cash & Equivalents | $36.79M | $26.63M | $13.27M | $23.77M | $21.10M | $30.34M | $13.65M | $22.78M | $28.26M | $3.93M |
| Operating Cash Flow | -$12.47M | $26.98M | -$17.14M | -$18.06M | -$14.22M | -$15.60M | -$9.06M | -$7.83M | -$3.64M | -$2.12M |
| Shares Outstanding | 34.16M | 27.53M | 27.03M | 26.36M | 26.01M | 26.00M | 19.90M | 19.90M | 18.41M | 13.64M |